Samil Pharmaceutical Co.,Ltd (KRX:000520)

KRX:000520 Statistics

Total Valuation

KRX:000520 has a market cap or net worth of KRW 218.03 billion. The enterprise value is 375.98 billion.

Market Cap	218.03B
Enterprise Value	375.98B

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

KRX:000520 has 21.23 million shares outstanding. The number of shares has increased by 25.18% in one year.

Current Share Class	21.23M
Shares Outstanding	21.23M
Shares Change (YoY)	+25.18%
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	23.77%
Owned by Institutions (%)	3.57%
Float	15.30M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.01
PB Ratio	1.52
P/TBV Ratio	1.57
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-13.89
EV / Sales	1.75
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-40.94

Financial Position

The company has a current ratio of 0.61, with a Debt / Equity ratio of 1.15.

Current Ratio	0.61
Quick Ratio	0.28
Debt / Equity	1.15
Debt / EBITDA	n/a
Debt / FCF	-17.91
Interest Coverage	-1.57

Financial Efficiency

Return on equity (ROE) is -17.04% and return on invested capital (ROIC) is -3.29%.

Return on Equity (ROE)	-17.04%
Return on Assets (ROA)	-2.71%
Return on Invested Capital (ROIC)	-3.29%
Return on Capital Employed (ROCE)	-7.18%
Revenue Per Employee	368.85M
Profits Per Employee	-46.42M
Employee Count	583
Asset Turnover	0.56
Inventory Turnover	4.02

Taxes

Income Tax	-2.48B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.13% in the last 52 weeks. The beta is 0.37, so KRX:000520's price volatility has been lower than the market average.

Beta (5Y)	0.37
52-Week Price Change	-19.13%
50-Day Moving Average	10,092.40
200-Day Moving Average	11,009.20
Relative Strength Index (RSI)	52.73
Average Volume (20 Days)	368,498

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:000520 had revenue of KRW 215.04 billion and -27.06 billion in losses. Loss per share was -1,296.71.

Revenue	215.04B
Gross Profit	78.20B
Operating Income	-16.54B
Pretax Income	-29.54B
Net Income	-27.06B
EBITDA	-3.51B
EBIT	-16.54B
Loss Per Share	-1,296.71

Balance Sheet

The company has 6.49 billion in cash and 164.45 billion in debt, giving a net cash position of -157.95 billion or -7,440.19 per share.

Cash & Cash Equivalents	6.49B
Total Debt	164.45B
Net Cash	-157.95B
Net Cash Per Share	-7,440.19
Equity (Book Value)	143.09B
Book Value Per Share	6,734.69
Working Capital	-58.02B

Cash Flow

In the last 12 months, operating cash flow was -2.32 billion and capital expenditures -6.87 billion, giving a free cash flow of -9.18 billion.

Operating Cash Flow	-2.32B
Capital Expenditures	-6.87B
Free Cash Flow	-9.18B
FCF Per Share	-432.60

Margins

Gross margin is 36.37%, with operating and profit margins of -7.69% and -12.59%.

Gross Margin	36.37%
Operating Margin	-7.69%
Pretax Margin	-13.74%
Profit Margin	-12.59%
EBITDA Margin	-1.63%
EBIT Margin	-7.69%
FCF Margin	n/a

Dividends & Yields

KRX:000520 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.18%
Shareholder Yield	-25.18%
Earnings Yield	-12.41%
FCF Yield	-4.21%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 24, 2023. It was a forward split with a ratio of 1.1.

Last Split Date	Mar 24, 2023
Split Type	Forward
Split Ratio	1.1

Scores

KRX:000520 has an Altman Z-Score of 0.89 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.89
Piotroski F-Score	3